(Q54362486)

English

Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Xiao-Su Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yan-Rong Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hong-Hu Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lan-Ping Xu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Dai-Hong Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kai-Yan Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

91

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

183-192

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Minimal residual disease studies by flow cytometry in acute leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Flow Cytometric Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC).

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Identifiers

10.1007/S00277-011-1285-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54362486&oldid=1767157603"